STOCK COMPARISON
Lonza Group vs Thermo Fisher Scientific: Fair Value & Quality
Both stocks run through our valuation models. Here is how Lonza Group (LONN) and Thermo Fisher Scientific (TMO) compare, as of Aug 10, 2026.
As of Aug 10, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Lonza Group trades at CHF 572 versus a fair value of CHF 260 (-55%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Lonza Group
LONN.SW · CHF · Health Care
-55%
upside to fair value
overvalued
PriceCHF 572
Fair ValueCHF 260
Quality55/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$594
Fair Value$308
Quality63/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Lonza GroupThermo Fisher Scientific
Valuation
43.7×P/E (TTM)29.5×
7.51×P/S (TTM)4.41×
5.37×P/B3.74×
24.4×EV/EBITDA20.0×
1.67×PEG1.74×
0.9%Dividend yield0.3%
CHF 5.00Dividend per share$1.76
Profitability
-4%Net margin15%
21%Operating margin18%
10%Return on equity14%
5%Return on assets5%
Growth
17%Revenue growth (YoY)6%
1.6%Avg. growth/yr (3Y)-0.3%
7.7%Avg. growth/yr (5Y)6.7%
Balance & size
0.42×Debt / equity0.67×
$49BMarket cap$199B
expensiveGrowth qualityhealthy
Even match: 7 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Lonza Groupof which business quality 53 · market factors 62
Thermo Fisher Scientificof which business quality 60 · market factors 65
ProfitabilityMargins and returns on capital today
38
43
Quality GrowthAre margins and returns improving?
46
31
CashflowEarnings quality: real cash, not paper profit
30
62
Fin. StrengthBalance sheet, leverage, solvency risk
64
60
InvestmentDisciplined investing over empire-building
62
79
Low VolatilityCalm price path (market factor)
79
68
MomentumPrice trend over the last 3–12 months (market factor)
53
58
52W MomentumDistance to the 52-week high (market factor)
61
72
Net IssuanceBuybacks instead of dilution
98
97
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Lonza Group
DCF ModelsCHF 50.97
Earnings-BasedCHF 114
Dividend DiscountCHF 68.14
MultiplesCHF 261
Asset-BasedCHF 87.62
Economic ProfitCHF 141
Growth EarningsCHF 260
17 of 17 models see the stock below the current price.
Thermo Fisher Scientific
DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Lonza Group
Bear CHF 182Fair Value CHF 260Bull CHF 338
CHF 572 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$594 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Lonza Group · Health Care
Quality score55 · above median
Fair value upside-55% · below median
Thermo Fisher Scientific · Health Care
Quality score63 · above median
Fair value upside-48% · below median
Bottom line
As of Aug 10, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Lonza Group trades at CHF 572 versus a fair value of CHF 260 (-55%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Thermo Fisher Scientific has the higher quality score (63/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
